← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Arima Genomics, Inc.
San Diego, CA
$15,834,342
Total funding
7
Grants
Funding over time
peak $3.2M · FY2016–24$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$15,834,342 · 7
By mechanism
R44$15,760,763 · 6
R41$73,579 · 1
Investigators at Arima Genomics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors$2,069,712
R44 · FY2023 · CA
Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors$1,913,603
R44 · FY2024 · CA
Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information$1,573,140
R44 · FY2018 · HG
A scalable kit-based assay for multi-omic analyses of transcriptional protein binding and chromatin interactions from ultra-low input frozen and FFPE samples at single-cell resolution$1,085,125
R44 · FY2021 · HG
Scalable single-cell workflow for multiomic analyses of chromatin interactions, accessibility, gene expression and cell surface proteins to unravel mechanisms of cellular diversity$1,084,321
R44 · FY2024 · GM
A low-input compatible, end-to-end kitted HiChIP workflow for concurrent analyses of transcriptional protein binding and chromatin interactions toward a mechanistic understanding of gene regulation$1,074,115
R44 · FY2021 · GM
A scalable kit-based assay for multi-omic analyses of transcriptional protein binding and chromatin interactions from ultra-low input frozen and FFPE samples at single-cell resolution$1,015,129
R44 · FY2022 · HG
Scalable single-cell workflow for multiomic analyses of chromatin interactions, accessibility, gene expression and cell surface proteins to unravel mechanisms of cellular diversity$1,013,363
R44 · FY2023 · GM
Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies$999,273
R44 · FY2021 · CA
Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies$999,273
R44 · FY2020 · CA
A low-input compatible, end-to-end kitted HiChIP workflow for concurrent analyses of transcriptional protein binding and chromatin interactions toward a mechanistic understanding of gene regulation$982,776
R44 · FY2022 · GM
Commercialization of a low-cost user-friendly DNA preparation kit that produces chromosome-span contiguity from conventional short-read sequencingââ for a wide range of applications$928,154
R44 · FY2018 · HG
Commercialization of a low-cost user-friendly DNA preparation kit that produces chromosome-span contiguity from conventional short-read sequencingââ for a wide range of applications$848,530
R44 · FY2017 · HG
Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information$174,249
R44 · FY2019 · HG
Optimizing HaploSeq for whole-genome phased haplotypes in biomedical applications$43,503
R41 · FY2016 · HG
Optimizing HaploSeq for whole-genome phased haplotypes in biomedical applications$30,076
R41 · FY2016 · HG